Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ling Chu

Showing results (441-450 of 448) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 448 results.
Infection and Immunity|March 21, 2022
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli InfectionsLaurent Chorro, Zhenghui Li, Ling Chu, et al.
Developmental Cell|July 30, 2014
EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4Ruey-Hwang Chou, Ying-Nai Wang, Yi-Hsien Hsieh, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Scientific Reports|June 17, 2024
Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infectionSofia Sintoris, Justyna M Binkowska, Jonathan L Gillan, et al.
Cancers|August 26, 2023
High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic ApproachChin-Mu Hsu, Kung-Chao Chang, Tzer-Ming Chuang, et al.
Clinical Lung Cancer|January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on OsimertinibPascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2025
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort ABenjamin Besse, Koichi Goto, Yongsheng Wang, et al.
Pageof 45

Showing results (441-450 of 448) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 448 results.
Infection and Immunity|March 21, 2022
Preclinical Immunogenicity and Efficacy of Optimized O25b O-Antigen Glycoconjugates To Prevent MDR ST131 E. coli InfectionsLaurent Chorro, Zhenghui Li, Ling Chu, et al.
Developmental Cell|July 30, 2014
EGFR modulates DNA synthesis and repair through Tyr phosphorylation of histone H4Ruey-Hwang Chou, Ying-Nai Wang, Yi-Hsien Hsieh, et al.
Journal of Medicinal Chemistry|July 9, 2014
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agentsMei-Juan Wang, Ying-Qian Liu, Ling-Chu Chang, et al.
Scientific Reports|June 17, 2024
Nasal cathelicidin is expressed in early life and is increased during mild, but not severe respiratory syncytial virus infectionSofia Sintoris, Justyna M Binkowska, Jonathan L Gillan, et al.
Cancers|August 26, 2023
High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic ApproachChin-Mu Hsu, Kung-Chao Chang, Tzer-Ming Chuang, et al.
Clinical Lung Cancer|January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on OsimertinibPascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.
Cell Reports|May 26, 2026
Host-microbial interactions at the nasal mucosa in young children and adults: A retrospective, cross-sectional studyJesús Reiné, Lisa A King, Youvika Singh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2025
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort ABenjamin Besse, Koichi Goto, Yongsheng Wang, et al.
Pageof 45